Marco E. Bianchi

Medicine & Life Sciences

1. HMGB1 Protein 100%
2. High Mobility Group Proteins 32%
3. Receptor for Advanced Glycation End Products 27%
4. DNA 26%
5. Chromatin 24%
6. Inflammation 19%
7. Oxidation-Reduction 17%
8. pembrolizumab 16%
9. HMGB Proteins 15%
10. HMGB2 Protein 14%
11. Muscles 13%
12. Nuclear Proteins 13%
13. Alarmins 13%
14. Proteins 13%
15. Nucleosomes 11%
16. Leukocytes 10%
17. Histones 10%
18. Genes 10%
19. Transcription Factors 10%
20. Regeneration 10%
21. Cytokines 9%
22. Urinary Bladder Neoplasms 9%
23. Macrophages 8%
24. Neoplasms 8%
25. Disulfides 7%
26. Mesothelioma 7%
27. Protein Isoforms 7%
28. Dendritic Cells 7%
29. Malignant Mesothelioma 7%
30. Stem Cells 6%
31. Cell Movement 6%
32. Cruciform DNA 5%
33. In Vitro Techniques 5%
34. Toll-Like Receptor 4 5%
35. Wounds and Injuries 5%
36. kinked DNA 5%
37. Muscular Dystrophies 5%
38. Blood Platelets 5%
39. Neutrophils 5%
40. Rec A Recombinases 5%
41. Cysteine 5%
42. Monocytes 5%
43. Chemokines 5%
44. E coli recA protein 5%